Fresh From the Bench: Latest Federal Circuit Court Case
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Google LLC v. Hammond Development International, Inc., Appeal No. 2021-2218 (Fed. Cir. Dec. 8, 2022)
In the only precedential patent decision this week, the Federal Circuit issued a decision concerning the effect of collateral estoppel in an inter partes review (IPR) based on a previous IPR decision. The Court affirmed an obviousness finding where the Patent Trial and Appeal Board's (PTAB) prior, final, unappealed written decision concerning a related patent would have been dispositive of obviousness over the patent at issue.
The ’816 patent at issue “discloses a communication system that allows a communication device to remotely execute one or more applications.” Google petitioned for IPR of all claims of the ’816 patent, asserting all claims would have been obvious in view of several combinations of prior art. “On June 4, 2021, the Board held claims 1-13 and 20-30 would have been obvious over combinations.” The PTAB further determined that Google failed to show claims 14-19 would have been unpatentable as obvious. Google appealed the PTAB’s final written decision as to claims 14-19. Google previously petitioned for IPR of a related patent—the ’483 patent. The ’816 patent and the ’483 patent share the same specification. Several months prior to the PTAB’s finding on the ’816 patent, the PTAB issued a final written decision finding all challenged claims of the ’483 patent would have been obvious. Hammond did not appeal the PTAB’s final written decision on the ’483 patent, and that decision became final on June 14, 2021.
Read more.
By Annie White
Edited by Nika Aldrich and Scott D. Eads, at Schwabe, Williamson & Wyatt
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…